DR Charles Deflandre X-RAY SRL
DR Charles Deflandre X-RAY reported revenue of 0 € for the 2026 financial year (annual accounts filed with the NBB on 14 Oct 2026).
The score of DR Charles Deflandre X-RAY shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2024 → 2026: Equity +432 % Total assets +308 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR Charles Deflandre X-RAY's annual accounts
| 2026 | 2025 | 2024 | |
|---|---|---|---|
| Revenue | 0 € | ||
| Net result | 271,918 € | ||
| Equity | 622,679 € | ||
| Cash | 22,537 € | ||
| EBITDA | 365,490 € | ||
| Total assets | 719,698 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 14 Oct 2026
- Year ended 31 Mar 2025filed on 29 Sep 2025
- Year ended 31 Mar 2024filed on 17 Oct 2024
DR Charles Deflandre X-RAY's financial analysis
- Solvency86.5%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR Charles Deflandre X-RAY
DR Charles Deflandre X-RAY's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0801.683.620
- VAT number
- BE0801683620
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 11 May 2023
- Registered office
- 4920 Aywaille
- Latest accounts
- 2026 · filed on 14 Oct 2026
- Activity
- Medical specialists activities (NACE 86220)
DR Charles Deflandre X-RAY (SRL) has been based in Aywaille since 2023, active in: medical specialists activities. For 2026, it reports revenue of 0 €, a net profit of 271,918 € and equity of 622,679 €. Its solvency stands at 86.5%, above the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DR Charles Deflandre X-RAY
Companies in the same business, of comparable size and area, outside its group.
- Lammens Consulting en Marketing Co Manufacture of basic pharmaceutical products Ronse · balance sheet 719,700 €
- Refugie van Tongerlo Kortenberg · balance sheet 719,937 €
- GAT Export Business and other management consultancy activities Brussels · balance sheet 720,086 €
- Dapper Computer programming activities Boechout · balance sheet 720,523 €
- CMP R&S Rental and operating of own or leased real estate Esneux · balance sheet 757,497 €
- AJPF Chaumont-Gistoux · balance sheet 718,932 €
- Union industrielle du Borinage Lasne · balance sheet 720,539 €
Frequently asked questions about DR Charles Deflandre X-RAY
What is the revenue of DR Charles Deflandre X-RAY?
According to the 2026 annual accounts filed with the NBB, the revenue of DR Charles Deflandre X-RAY amounts to 0 €.
What is the VAT number of DR Charles Deflandre X-RAY?
In Belgium, the VAT number is the company number prefixed with BE: BE0801683620 for DR Charles Deflandre X-RAY, if the company is VAT-registered. Its company number (CBE) is 0801.683.620.
Where is the registered office of DR Charles Deflandre X-RAY?
According to the CBE register, the registered office of DR Charles Deflandre X-RAY is in 4920 Aywaille.
What is the equity of DR Charles Deflandre X-RAY?
At the close of the 2026 financial year, the equity of DR Charles Deflandre X-RAY amounts to 622,679 €, a solvency of 86.5% of total assets.
Who manages DR Charles Deflandre X-RAY?
The register lists 1 active mandates at DR Charles Deflandre X-RAY. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR Charles Deflandre X-RAY
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →